Showing results (171-180 of 741) with videos related to
Sort By:
Pageof 75
American Journal of Hematology|November 13, 2014
Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosisGregory P Kaufman, Angela Dispenzieri, Morie A Gertz, et al.Clinical Lymphoma, Myeloma & Leukemia|December 22, 2023
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple MyelomaSarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2005
Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology GroupS Vincent Rajkumar, Emily Blood, David Vesole, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009
Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendationsJoan Bladé, Meletios Dimopoulos, Laura Rosiñol, et al.Nature Reviews. Clinical Oncology|July 29, 2026
De-escalation trials in multiple myeloma: past, present and futureHira Mian, Luciano J Costa, Mohamad Mohty, et al.Frontiers in Oncology|May 16, 2022
Dual-Targeted Therapy Circumvents Non-Genetic Drug Resistance to Targeted TherapyWei Wang, Yue Sun, Xiaobo Liu, et al.Cancer|June 29, 2019
Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysisRonan W Hsieh, Ronald S Go, Jithma P Abeykoon, et al.American Journal of Hematology|March 11, 2015
Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin TAngela Dispenzieri, Morie A Gertz, Amy Saenger, et al.American Journal of Hematology|February 4, 2020
Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosisSurbhi Sidana, Eli Muchtar, M Hasib Sidiqi, et al.American Journal of Hematology|October 13, 2016
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluationYi L Hwa, Qian Shi, Shaji K Kumar, et al.Pageof 75